Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Artemisinin is a sesquiterpene lactone derived from Artemisia annua that disrupts cellular iron homeostasis and generates reactive oxygen species. It demonstrates potent antimalarial activity and shows promising anti-cancer properties through targeted cell death mechanisms.
Origin & History
Artemisinin is a sesquiterpene lactone isolated from the leaves of sweet wormwood (*Artemisia annua*), an herb native to temperate China used in traditional Chinese medicine. First extracted in the 1970s through a Chinese government antimalarial project, it is typically obtained through solvent-based extraction methods using ethanol or petroleum ether from dried leaves.
Research Narrative (Provisional)
Large-scale phase III RCTs (n=1100) across Southeast Asia demonstrated artemisinin-based combination therapies achieved 98% cure rates for drug-resistant malaria (PMID: 32171078). Meta-analyses of 5 RCTs (n=772) confirmed comparable efficacy to other antimalarial combinations (PMID: 33013398), while phase I cancer trials established safety profiles for oral (200mg/day) and IV (18mg/kg) formulations.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Artemisinin is a purified bioactive sesquiterpene lactone compound, not a whole food or nutritional ingredient; it contains no meaningful macronutrients (carbohydrates, fats, proteins), dietary fiber, vitamins, or minerals in pharmacologically relevant doses. Key bioactive compound: Artemisinin (C15H22O5, MW 282.33 g/mol) — the defining constituent, characterized by an endoperoxide bridge (1,2,4-trioxane ring) essential for biological activity. Typical therapeutic doses range from 200–500 mg/day in clinical settings. Bioavailability: Oral bioavailability is approximately 32% due to extensive first-pass hepatic metabolism; peak plasma concentration (Cmax) reached within 1–2 hours post-ingestion. Half-life: approximately 2–3 hours. The compound undergoes auto-induction of CYP2B6 and CYP3A4 enzymes, reducing plasma levels with repeated dosing by up to 50–70% after 5–7 days. Semi-synthetic derivatives (artesunate, artemether, dihydroartemisinin) exhibit improved bioavailability of 80–90%. No clinically significant micronutrient content. Fat-soluble properties enhance absorption when taken with lipid-containing food, increasing AUC by approximately 30%. Concentrated plant-source (Artemisia annua) aerial parts contain approximately 0.01–0.8% artemisinin by dry weight, alongside minor flavonoids (artemetin, casticin) and essential oils, but isolated pharmaceutical-grade artemisinin is a single purified compound.
Reported Mechanism (Provisional)
Artemisinin contains an endoperoxide bridge that reacts with intracellular iron, particularly heme iron in malaria parasites, generating cytotoxic free radicals and alkylating proteins. The compound disrupts mitochondrial function and triggers apoptosis through oxidative stress pathways. In cancer cells, artemisinin exploits elevated iron levels to selectively induce cell death while sparing healthy cells.
Clinical Narrative (Provisional)
Phase III randomized controlled trials involving over 1,400 patients showed artemisinin-based combination therapies achieved 98% cure rates for uncomplicated malaria versus 48% for conventional treatments. Phase I cancer studies with 24-36 participants demonstrated safety at oral doses up to 200mg daily, with preliminary anti-proliferative effects observed in breast and colorectal cancer patients. Multiple systematic reviews confirm artemisinin's superiority over chloroquine and other antimalarials, though cancer research remains in early-stage clinical development. Current evidence strongly supports antimalarial use but cancer applications require larger controlled trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.